Skip to main content


Erratum to: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer

The original article was published in BMC Cancer 2016 16:822


After the publication of the article [1], the authors realised it contained an error with the Methods section. The following paragraph should be deleted from the original article:

Cell proliferation assay

Proliferation was measured using Delfia cell proliferation kit (Perkin-Elmer, Waltham, MA, USA) according to manufacturer protocol. BrdU incorporation was measured by time–resolved fluorescence 48 h after transfection using VictorX4 multimode plate reader (Perkin-Elmer, Waltham, MA, USA). All experiments were performed in triplicates and repeated tree times.

Please note that the original article was corrected.


  1. 1.

    Torres A, et al. In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer. BMC Cancer. 2016;16:822. doi:10.1186/s12885-016-2867-z.

Download references

Author information

Correspondence to Anna Torres.

Additional information

The online version of the original article can be found under doi:10.1186/s12885-016-2867-z.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark